Brainsway Ltd..
Medical technology company
- Reports this week
- 0
- Active events
- 0
- Connections
- 29
What's happening
One to three months ago
-
Brainsway Ltd. requires FDA clearance for its Deep TMS protocol, tied to regional market growth in North America.Some support1 report
-
Brainsway Ltd. listed its American Depositary Receipts (ADRs) on the Nasdaq stock exchange. Harel Insurance Investments was also involved in a stake purchase.Some support12 reports
Gone quiet
No new reports in 90+ days-
Brainsway Ltd. is expanding its policy coverage across the U.S. and gaining favorable policy coverage in South Carolina.Some support1 report
-
Brainsway Ltd. and Boston Scientific operate in the medical device industry.Speculative1 report
-
Brainsway Ltd. obtained three FDA-cleared indications for its proprietary Deep TMS platform technology.Some support2 reports
-
Brainsway Ltd. received upward earnings estimate revisions on August 19, 2025.Some support4 reports
-
BrainsWay invests in Axis Integrated Mental Health to expand access to care, following previous investments in Stella.Some support1 report
-
Brainsway Ltd. secured a strategic investment that is expected to expand its market reach.Some support2 reports
-
BrainsWay Ltd. provided a strategic investment to Neurolief, which is awaiting FDA approval for its drug Proliv™Rx.Some support1 report1 development inside
No events began in the chosen period. Widen it, or reset.
Around Brainsway Ltd. this week
News at the entities that move Brainsway Ltd. most-
FDA StructuralGeneric medicine services are seeking approval for launch from the FDA.Moves Brainsway Ltd.
-
SWIFT OperationalIBM has enabled a connection to SWIFT's shared ledger system.Moves Brainsway Ltd.
-
South Carolina StructuralMatthew Rutter attended a convention held in North Carolina on June 19, 2026.Moves Brainsway Ltd.
-
MarketBeat Mentioned togetherApple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Moves Brainsway Ltd.
-
Renaissance Technologies TransactionalRenaissance Technologies holds a significant stake in Lite Strategy, Inc., whose stock trades on the Nasdaq exchange.Moves Brainsway Ltd.
-
Royal Bank of Canada TransactionalRoyal Bank of Canada raised its holdings in the Dimensional US Sustainability Core 1 ETF on June 19, 2026.Moves Brainsway Ltd.
Connections
The 13 strongest of 29, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
FDA Structural
The FDA formally regulates Brainsway Ltd., granting it market indications for its products.
-
Harel Insurance Investments & Financial Services Ltd. Transactional
Harel Insurance Investments & Financial Services Ltd. acquired a new stake in Brainsway Ltd. in July 2026.
-
Nasdaq Structural
Brainsway Ltd. maintains a formal ADR listing on the Nasdaq stock exchange.
-
SEC Structural
Brainsway Ltd. must comply with the regulatory requirements and filing mandates of the SEC to operate.
-
SWIFT Operational
SWIFT's financial infrastructure facilitates the acceleration of Brainsway's Deep TMS protocol adoption.
-
Renaissance Technologies Transactional
Renaissance Technologies increased its investment stake in Brainsway Ltd. during Q1.
-
South Carolina Structural
Brainsway Ltd. is gaining favorable policy coverage and benefiting from the regulatory environment of South Carolina.
-
Royal Bank of Canada Transactional
Royal Bank of Canada increased its investment holdings in Brainsway Ltd.
Show all 13 connections
-
Burlington Shared context
Brainsway Ltd. operates and reports results from the location of Burlington.
-
MarketBeat Mentioned together
MarketBeat provides and hosts stock performance ratings and consensus recommendations for Brainsway Ltd.
-
Jerusalem Shared context
Brainsway Ltd. operates and reports financial results from Jerusalem.
-
North America Shared context
Brainsway Ltd.'s market growth is linked to the regional demand dynamics of North America.
-
TMS Mentioned together
The evidence describes TMS's operations but does not mention or describe any relationship with Brainsway Ltd.
History
Events by the month they beganJuly 2026
2 eventsJune 2026
7 events- Brainsway Ltd. is expanding its policy coverage across the U.S. and gaining favorable policy coverage in South Carolina.
- Brainsway Ltd. and Boston Scientific operate in the medical device industry.
- Brainsway Ltd. obtained three FDA-cleared indications for its proprietary Deep TMS platform technology.
- Brainsway Ltd. received upward earnings estimate revisions on August 19, 2025.
- BrainsWay invests in Axis Integrated Mental Health to expand access to care, following previous investments in Stella.
- Brainsway Ltd. secured a strategic investment that is expected to expand its market reach.
- BrainsWay Ltd. provided a strategic investment to Neurolief, which is awaiting FDA approval for its drug Proliv™Rx.